Arizona is suing a major drug maker, accusing it of gaming the system by simply renaming an asthma drug to increase its ...

Shanon and William Schmidtknecht, of Poynette, filed their lawsuit in federal court in Milwaukee on Jan. 21, a year to the ...

GlaxoSmithKline "deliberately" discontinued a widely-used asthma medication in order to reap profits and families suffered, ...

The lawsuit filed in Maricopa County Superior Court contends GlaxoSmithKline's actions violate the Arizona Consumer Fraud Act ...

The state’s top lawyer accused a British multinational drug company of “deceptive and unfair practices” that endangered lives and exploited American taxpayers.

Interventions: Patients entered a 4-week, open run-in period, receiving fluticasone propionate 50µg twice daily via a Diskus™ inhalation device. Patients whose asthma was well controlled ...

The Annals of Pharmacotherapy. 2009;43(3):519-527.

A young man with severe asthma used to be able to get his inhaler for cheap, but after UnitedHealthcare's drug arm jacked up the price, he had to go without — and it ultimately killed him ...

Seretide (salmeterol xinafoate/fluticasone propionate ... under the Sirdupla brand name and in a pressurised metered dose inhaler (pMDI) device developed by 3M. Like its branded rival ...

The root of the U.S.’s high prescription drug prices lies in its unique system, which allows pharmaceutical manufacturers to ...

Abingworth agreed a similarly structured deal with Teva focused on the development of TEV-'248 as a dual-action asthma rescue inhaler based on inhaled corticosteroid (ICS) fluticasone propionate ...